Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 3/2/22 → 1/24/24 |
Funding
- Eli Lilly and Company: $28,550.00
PIONEER-PEDS1-H8H-MC-LAHV(a): Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine
- Qaiser, Sharoon (PI)